Back to Search Start Over

Novo Nordisk to invest 2.1 billion Euros to expand existing production site in Chartres, France

Source :
PharmaBiz. November 27, 2023
Publication Year :
2023

Abstract

Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion Euros) starting in 2023 to expand the existing production site in Chartres, France, for the current [...]

Subjects

Subjects :
Novo Nordisk A/S -- Production processes
Chronic diseases
Pharmaceutical industry -- Production processes
Quality control -- Production management -- Production processes
Quality control
Pharmaceuticals and cosmetics industries

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.774307275

Tools

Authors Abstract Subjects Details